Ultrastructural features of CD34+ hematopoietic progenitor cells from bonemarrow, peripheral blood and umbilical cord blood

Citation
Gl. Deliliers et al., Ultrastructural features of CD34+ hematopoietic progenitor cells from bonemarrow, peripheral blood and umbilical cord blood, LEUK LYMPH, 42(4), 2001, pp. 699-708
Citations number
29
Categorie Soggetti
Hematology,"Onconogenesis & Cancer Research
Journal title
LEUKEMIA & LYMPHOMA
ISSN journal
10428194 → ACNP
Volume
42
Issue
4
Year of publication
2001
Pages
699 - 708
Database
ISI
SICI code
1042-8194(200108)42:4<699:UFOCHP>2.0.ZU;2-F
Abstract
Hematopoietic progenitor cells from different sources have been widely char acterized, but their ultrastructural morphology has never been described in detail. In this study, imunomagnetically separated CD34(+) cells from norm al bone marrow (BM), mobilized peripheral blood (PBSC) and human umbilical cord blood (CB) were studied by transmission electron microscopy (TEM) usin g a cytochemical method which reveals endogenous myelo-peroxidase (MPO) act ivity. This technique is particularly suited for detecting early signs of t he myeloid commitment. The CD34(+) cells from PBSC were morphologically ver y homogeneous and 94.7 +/- 4.5% of these cells were MPO-: these ultrastruct ural features are generally considered typical of immature cells. The CD34( +) BM cells were instead more heterogeneous, with 24.6 +/- 7.4% showing int ense MPO activity. The ultrastructural characteristics of CB cells fell bet ween those observed in PBSC and BM, but there was a high percentage of morp hologically immature cells with no evidence of MPO activity (about 83%). Th e number of apoptotic cells within samples from different sources was also examined both by TEM and flow cytometry. The percentage of apoptotic cells was 0.7% in PBSC. 2.3% in BM, 2.9% in CB from vaginal delivery and 11.6% in CB from cesarean section. These observations confirm the relative phenotyp ic immaturity of CB in comparison with BM cells; they also suggest that CB collected after cesarean section may be associated with reduced stem cells viability.